Vlahovic, G., Archer, G. E., Lally-Goss, D., Norman, S., Desjardins, A., Peters, K. B., … Sampson, J. H. (2014). Regulatory T-cell inhibition plus antitumor immunotherapy targeted against cytomegalovirus (CMV) in patients with newly diagnosed glioblastoma multiforme (GBM). In Journal of Clinical Oncology (Vol. 32, pp. 3069–3069). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2014.32.15_suppl.3069

Vlahovic, Gordana, Gerald E. Archer, Denise Lally-Goss, Sharon Norman, Annick Desjardins, Katherine B. Peters, Tulika Ranjan, et al. “Regulatory T-cell inhibition plus antitumor immunotherapy targeted against cytomegalovirus (CMV) in patients with newly diagnosed glioblastoma multiforme (GBM).” In Journal of Clinical Oncology, 32:3069–3069. American Society of Clinical Oncology (ASCO), 2014. https://doi.org/10.1200/jco.2014.32.15_suppl.3069.

Vlahovic G, Archer GE, Lally-Goss D, Norman S, Desjardins A, Peters KB, et al. Regulatory T-cell inhibition plus antitumor immunotherapy targeted against cytomegalovirus (CMV) in patients with newly diagnosed glioblastoma multiforme (GBM). In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2014. p. 3069–3069.

Vlahovic, Gordana, et al. “Regulatory T-cell inhibition plus antitumor immunotherapy targeted against cytomegalovirus (CMV) in patients with newly diagnosed glioblastoma multiforme (GBM).” Journal of Clinical Oncology, vol. 32, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2014, pp. 3069–3069. Crossref, doi:10.1200/jco.2014.32.15_suppl.3069.

Vlahovic G, Archer GE, Lally-Goss D, Norman S, Desjardins A, Peters KB, Ranjan T, Watts J, Healy P, Herndon JE, Friedman HS, Friedman AH, Bigner DD, Sampson JH. Regulatory T-cell inhibition plus antitumor immunotherapy targeted against cytomegalovirus (CMV) in patients with newly diagnosed glioblastoma multiforme (GBM). Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2014. p. 3069–3069.